The Latest Breaking News from 1Life Healthcare

 

Upgrades

According to data from Benzinga Pro, during Q1, 1Life Healthcare's (NASDAQ:ONEM) reported sales totaled $254.10 million. Despite a 4.79% increase in earnings, the company posted a loss of $90.86 million.

Over the past 3 months, 6 analysts have published their opinion on 1Life Healthcare (NASDAQ:ONEM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1Life Healthcare (NASDAQ:ONEM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings 1Life Healthcare beat estimated earnings by 4.08%, reporting an EPS of $-0.47 versus an estimate of $-0.49.

Gainers 1Life Healthcare (NASDAQ:ONEM) shares moved upwards by 22.4% to $9.58 during Wednesday's after-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q1 earnings came out today.

Upgrades

1Life Healthcare (NASDAQ:ONEM) has observed the following analyst ratings within the last quarter:

Within the last quarter, 1Life Healthcare (NASDAQ:ONEM) has observed the following analyst ratings: